VEGFA and interstitial lung disease: However, severe toxicities have recently emerged, such as interstitial lung disease due to epidermal growth factor receptor-tyrosine kinase inhibitors [1] and bleeding or perforation events due to vascular endothelial growth factor (VEGF)-targeted agents [2].